We also wish to congratulate our 2 finalists who submitted outstanding projects,
Lyra Medical and Reability.
The Merage Institute - Mayo Program aims at encouraging collaborations between Israeli medical start-up companies and the Mayo Clinic, with the objective of accelerating availability of medical innovation to the public.
The Merage Institute - Mayo Program is open to Israeli start-ups that are developing viable innovative technologies striving to help the world in the medical space in areas of interest to the Mayo clinic.
For a duration of 12-36 months, selected projects are integrated into the relevant research units at Mayo, under the supervision of a Mayo researcher. The Merage Institute provides up to $150,000 a year to the Mayo Clinic, to cover the direct collaboration costs of the selected project. In addition, the program offers the opportunity to work with leading practitioners and investigators, who routinely publish in prestigious national and international journals.
The Fellowship aims to involve participants actively in the work and research of leading personnel and the Mayo facility and personnel resources. It is not intended to primarily fund the completion of the research and/or development to bring the product to the market.
Fees for residence permits etc‘ are not included.
Applicants must be Israeli companies or Israeli citizens that have resided in Israel at least for two-and-a-half years in the five years before the application deadline.
The proposed project must be in a field where Mayo has active research. The engagement/agreement with the selected project will be directly and under the sole responsibility of Mayo.
The selected project team commits to carrying out all research and development activities in compliance with fundamental ethical principles.
Applications should contain:
All applications will be reviewed by the Merage Institute – Mayo committee and forwarded to the relevant medical group at the Mayo Clinic. The finalists will be reviewed by an independent review committee consistent of members from the Mayo Clinic, the Merage Institute and ad hoc members (the Jury).
Once a project is selected, the start up company and Mayo will negotiate an agreement. Funds will be provided directly to the Mayo Clinic. Use of funds will be at Mayo’s discretion according to this agreement.
The decision of the jury is final and no appeal is possible. All candidates will be informed of the outcome of their applications by e-mail.